AZoLifeSciences on MSN45m
Bispecific antibodies for SARS-CoV-2 variant neutralizationBispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback